scholarly article | Q13442814 |
P50 | author | Wendy J. Fantl | Q111444697 |
Lewis T. Williams | Q111445253 | ||
Jaime A. Escobedo | Q111458215 | ||
P2093 | author name string | F. McCormick | |
C. W. Turck | |||
G. A. Martin | |||
M. del Rosario | |||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 413-23 | |
P577 | publication date | 1992-05-01 | |
P1433 | published in | Cell | Q655814 |
P1476 | title | Distinct phosphotyrosines on a growth factor receptor bind to specific molecules that mediate different signaling pathways | |
P478 | volume | 69 |
Q30194697 | A 31-amino-acid N-terminal extension regulates c-Crk binding to tyrosine-phosphorylated proteins |
Q34661632 | A discoidin domain receptor 1/SHP-2 signaling complex inhibits alpha2beta1-integrin-mediated signal transducers and activators of transcription 1/3 activation and cell migration. |
Q33781691 | A function for phosphatidylinositol 3-kinase beta (p85alpha-p110beta) in fibroblasts during mitogenesis: requirement for insulin- and lysophosphatidic acid-mediated signal transduction |
Q24321185 | A human phosphatidylinositol 3-kinase complex related to the yeast Vps34p-Vps15p protein sorting system |
Q24600945 | A limited set of SH2 domains binds BCR through a high-affinity phosphotyrosine-independent interaction |
Q24337740 | A photoaffinity scan maps regions of the p85 SH2 domain involved in phosphoprotein binding |
Q30194817 | A region of the 85-kilodalton (kDa) subunit of phosphatidylinositol 3-kinase binds the 110-kDa catalytic subunit in vivo |
Q74505910 | A screening method of SH2 domain ligands and blockers using a solid phase binding |
Q24291278 | A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells |
Q26827433 | A tale of two collagen receptors, integrin β1 and discoidin domain receptor 1, in epithelial cell differentiation |
Q28286805 | A unique autophosphorylation site in the platelet-derived growth factor alpha receptor from a heterodimeric receptor complex |
Q24308705 | Activation of Src family kinases by colony stimulating factor-1, and their association with its receptor |
Q41441452 | Activation of p70/p85 S6 kinase by a pathway independent of p21ras |
Q37223924 | Activation of phosphatidylinositol 3-kinase by epidermal growth factor, basic fibroblast growth factor, and nerve growth factor in PC12 pheochromocytoma cells |
Q41471394 | Activation of phosphoinositide 3-kinase is required for PDGF-stimulated membrane ruffling |
Q24310840 | Activation of the SH2-containing phosphotyrosine phosphatase SH-PTP2 by its binding site, phosphotyrosine 1009, on the human platelet-derived growth factor receptor |
Q46226598 | Affinity, specificity, and kinetics of the interaction of the SHC phosphotyrosine binding domain with asparagine-X-X-phosphotyrosine motifs of growth factor receptors |
Q24310421 | Alpha 2-chimerin, an SH2-containing GTPase-activating protein for the ras-related protein p21rac derived by alternate splicing of the human n-chimerin gene, is selectively expressed in brain regions and testes |
Q46628781 | Alpha1 adrenergic receptors activate phosphatidylinositol 3-kinase in human vascular smooth muscle cells. Role in mitogenesis |
Q39610838 | An SH2 domain-containing 5' inositolphosphatase inhibits insulin-induced GLUT4 translocation and growth factor-induced actin filament rearrangement |
Q34052239 | An extended surface of binding to Trk tyrosine kinase receptors in NGF and BDNF allows the engineering of a multifunctional pan-neurotrophin. |
Q36701137 | Association and phosphorylation-dependent dissociation of proteins in the insulin receptor complex |
Q36550151 | Association between GRB2/Sos and insulin receptor substrate 1 is not sufficient for activation of extracellular signal-regulated kinases by interleukin-4: implications for Ras activation by insulin |
Q42016191 | Association of the insulin receptor and phosphatidylinositol 3-kinase requires a third component |
Q22009127 | Autophosphorylation of KDR in the kinase domain is required for maximal VEGF-stimulated kinase activity and receptor internalization |
Q24614033 | Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src |
Q46452809 | Beta PDGF receptor mutants defective for mitogenesis promote neurite outgrowth in PC12 cells |
Q24652890 | Binding of NCK to SOS and activation of ras-dependent gene expression |
Q30194700 | Binding of the Src SH2 domain to phosphopeptides is determined by residues in both the SH2 domain and the phosphopeptides |
Q37083934 | Binding specificity of SH2 domains: insight from free energy simulations |
Q36234748 | Biological function of PDGF-induced PI-3 kinase activity: its role in alpha PDGF receptor-mediated mitogenic signaling. |
Q33575831 | Bovine papillomavirus E5 protein induces oligomerization and trans-phosphorylation of the platelet-derived growth factor beta receptor |
Q72080393 | CD19 of B Cells as a Surrogate Kinase Insert Region to Bind Phosphatidylinositol 3-Kinase |
Q40017821 | CD28-mediated costimulation in the absence of phosphatidylinositol 3-kinase association and activation |
Q24610534 | CRK protein binds to two guanine nucleotide-releasing proteins for the Ras family and modulates nerve growth factor-induced activation of Ras in PC12 cells |
Q24336526 | CTLA-4 binding to the lipid kinase phosphatidylinositol 3-kinase in T cells |
Q41332143 | CTLA-4, a negative regulator of T-lymphocyte activation |
Q39451271 | Caveolin 1-mediated regulation of receptor tyrosine kinase-associated phosphatidylinositol 3-kinase activity by ceramide |
Q41566544 | Cell-free activation of a DNA-binding protein by epidermal growth factor |
Q39455488 | Cellular compartmentalization in insulin action: altered signaling by a lipid-modified IRS-1. |
Q40812896 | Cellular insulin action and insulin resistance |
Q24629213 | Cloning of a novel, ubiquitously expressed human phosphatidylinositol 3-kinase and identification of its binding site on p85 |
Q27323236 | Coarse-grained molecular simulation of epidermal growth factor receptor protein tyrosine kinase multi-site self-phosphorylation |
Q41653302 | Common and distinct elements in insulin and PDGF signaling |
Q42828420 | Compartmentalization of autocrine signal transduction pathways in Sis-transformed NIH 3T3 cells |
Q53426359 | Concomitant activation of pathways downstream of Grb2 and PI 3-kinase is required for MET-mediated metastasis |
Q36794168 | Conformational analysis of cyclic hexapeptides designed as constrained ligands for the SH2 domain of the p85 subunit of phosphatidylinositol-3-OH kinase |
Q37170738 | Construction of a disulfide-stabilized diabody against fibroblast growth factor-2 and the inhibition activity in targeting breast cancer. |
Q24315793 | Construction of an SH2 domain-binding site with mixed specificity |
Q40626553 | Contribution of the membrane-distal tyrosine in intracellular signaling by the granulocyte colony-stimulating factor receptor |
Q42797857 | Cross-talk between the platelet-derived growth factor and the insulin signaling pathways in 3T3-L1 adipocytes |
Q27642117 | Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides |
Q27729401 | Crystal structures of peptide complexes of the amino-terminal SH2 domain of the Syp tyrosine phosphatase |
Q24310206 | Csk inhibition of c-Src activity requires both the SH2 and SH3 domains of Src |
Q39610954 | Cyclin D1 expression mediated by phosphatidylinositol 3-kinase through mTOR-p70(S6K)-independent signaling in growth factor-stimulated NIH 3T3 fibroblasts |
Q36836176 | Cytoplasmic and nuclear localization sites of phosphatidylinositol 3-kinase in human osteosarcoma sensitive and multidrug-resistant Saos-2 cells |
Q40374535 | Definition of signals for neuronal differentiation |
Q28287661 | Demonstration of functionally different interactions between phospholipase C-gamma and the two types of platelet-derived growth factor receptors |
Q41814651 | Detection of a 60 kDa tyrosine-phosphorylated protein in insulin-stimulated hepatoma cells that associates with the SH2 domain of phosphatidylinositol 3-kinase |
Q42815996 | Differential effects of carboxy-terminal sequence deletions on platelet-derived growth factor receptor signaling activities and interactions with cellular substrates |
Q42844403 | Differentiation of peptide molecular recognition by phospholipase C gamma-1 Src homology-2 domain and a mutant Tyr phosphatase PTP1bC215S. |
Q28302000 | Direct association of Grb2 with the p85 subunit of phosphatidylinositol 3-kinase |
Q24613360 | Direct association of p110 beta phosphatidylinositol 3-kinase with p85 is mediated by an N-terminal fragment of p110 beta |
Q24310893 | Distinctive effects of the carboxyl-terminal sequence of the insulin-like growth factor I receptor on its signaling functions |
Q40946341 | Diverse signaling pathways activated by growth factor receptors induce broadly overlapping, rather than independent, sets of genes |
Q31712047 | Diversification of cardiac insulin signaling involves the p85 alpha/beta subunits of phosphatidylinositol 3-kinase |
Q36643816 | Efficient coupling with phosphatidylinositol 3-kinase, but not phospholipase C gamma or GTPase-activating protein, distinguishes ErbB-3 signaling from that of other ErbB/EGFR family members |
Q30195067 | En bloc substitution of the Src homology region 2 domain activates the transforming potential of the c-Abl protein tyrosine kinase |
Q36234800 | Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement |
Q28571849 | Epidermal growth factor-induced phosphatidylinositol 3-kinase activation and DNA synthesis. Identification of Grb2-associated binder 2 as the major mediator in rat hepatocytes |
Q40958225 | Epidermal growth factor-related peptides and the epidermal growth factor receptor in normal and malignant prostate |
Q41569759 | Epidermal-growth-factor receptors generate Ras.GTP more efficiently than insulin receptors |
Q41489707 | Farnesyltransferase as a target for anticancer drug design |
Q36232058 | Fc gamma receptor activation induces the tyrosine phosphorylation of both phospholipase C (PLC)-gamma 1 and PLC-gamma 2 in natural killer cells |
Q40727590 | Fc receptor-mediated signal transduction |
Q60063644 | Fishing in Src-infested waters |
Q28504776 | Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice |
Q40733286 | Focal adhesion as a signal transduction organelle |
Q36656886 | Functional specificity of cytoplasmic and transmembrane tyrosine kinases: identification of 130- and 75-kilodalton substrates of c-fps/fes tyrosine kinase in macrophages |
Q22008672 | Fyn associates with Cbl and phosphorylates tyrosine 731 in Cbl, a binding site for phosphatidylinositol 3-kinase |
Q74643559 | Gastrin stimulates the formation of a p60Src/p125FAK complex upstream of the phosphatidylinositol 3-kinase signaling pathway |
Q24610035 | Genetic analysis of a phosphatidylinositol 3-kinase SH2 domain reveals determinants of specificity |
Q33934157 | Genetic screening and functional characterization of PDGFRB mutations associated with basal ganglia calcification of unknown etiology |
Q34453826 | Gi2-mediated activation of the MAP kinase cascade |
Q28593533 | Growth factor-induced tyrosine phosphorylation of Hrs, a novel 115-kilodalton protein with a structurally conserved putative zinc finger domain |
Q28269071 | Guanosine Triphosphatase-Activating Protein-Associated Protein, But Not src-Associated Protein p68 in Mitosis, Is a Part of Insulin Signaling Complexes* |
Q40882225 | Heregulin-beta is especially potent in activating phosphatidylinositol 3-kinase in nontransformed human mammary epithelial cells |
Q24305821 | Hierarchy of binding sites for Grb2 and Shc on the epidermal growth factor receptor |
Q34386778 | Highly Specific Modulators of Protein Kinase C Localization: Applications to Heart Failure |
Q46116292 | IP3 receptor blockade fails to prevent intracellular Ca2+release by ET-1 and α-thrombin |
Q30194902 | Identification and Characterization of a High-Affinity Interaction Between v-Crk and Tyrosine-Phosphorylated Paxillin in CT10-Transformed Fibroblasts |
Q34981771 | Identification and cloning of centaurin-alpha. A novel phosphatidylinositol 3,4,5-trisphosphate-binding protein from rat brain |
Q41199335 | Identification of a domain within the carboxyl-terminal region of the beta platelet-derived growth factor (PDGF) receptor that mediates the high transforming activity of PDGF. |
Q38291369 | Identification of a putative Syp substrate, the PDGF beta receptor |
Q24595150 | Identification of c-erbB-3 binding sites for phosphatidylinositol 3'-kinase and SHC using an EGF receptor/c-erbB-3 chimera |
Q37556986 | Identification of retinal ganglion cell neuroprotection conferred by platelet-derived growth factor through analysis of the mesenchymal stem cell secretome |
Q24308600 | Identification of six novel autophosphorylation sites on fibroblast growth factor receptor 1 and elucidation of their importance in receptor activation and signal transduction |
Q24293518 | Identification of two C-terminal autophosphorylation sites in the PDGF beta-receptor: involvement in the interaction with phospholipase C-gamma |
Q24309883 | Identification of two juxtamembrane autophosphorylation sites in the PDGF beta-receptor; involvement in the interaction with Src family tyrosine kinases |
Q24291107 | Identification of tyrosine residues in constitutively activated fibroblast growth factor receptor 3 involved in mitogenesis, Stat activation, and phosphatidylinositol 3-kinase activation |
Q24314627 | In vivo binding properties of SH2 domains from GTPase-activating protein and phosphatidylinositol 3-kinase |
Q40956511 | Increased mitogenicity of an alphabeta heterodimeric PDGF receptor complex correlates with lack of RasGAP binding |
Q41617077 | Increasing Complexity of Ras Signal Transduction: Involvement of Rho Family Proteins |
Q40973684 | Inhibition of DNA synthesis by a farnesyltransferase inhibitor involves inhibition of the p70(s6k) pathway |
Q41131139 | Inhibition of MG-63 cell proliferation and PDGF-stimulated cellular processes by inhibitors of phosphatidylinositol 3-kinase |
Q72659475 | Inhibition of PDGF BB stimulated DNA synthesis in rat aortic vascular smooth muscle cells by the expression of a truncated PDGF beta receptor |
Q40887496 | Inhibition of the ras-dependent mitogenic pathway by phosphopeptide prodrugs with antiproliferative properties |
Q33832620 | Inhibition of tumor growth and metastasis by targeting tumor-associated angiogenesis with antagonists to the receptors of vascular endothelial growth factor |
Q40858638 | Insulin and IGF-I signaling through the insulin receptor substrate 1. |
Q41038789 | Insulin receptor substrate 1 antisense expression in an hepatoma cell line reduces cell proliferation and induces overexpression of the Src homology 2 domain and collagen protein (SHC). |
Q39750687 | Insulin receptor substrate and p55 orthologous adaptor proteins function in the Caenorhabditis elegans daf-2/insulin-like signaling pathway |
Q36824805 | Insulin-stimulated oocyte maturation requires insulin receptor substrate 1 and interaction with the SH2 domains of phosphatidylinositol 3-kinase |
Q28592322 | Interaction of fibroblast growth factor receptor 3 and the adapter protein SH2-B. A role in STAT5 activation |
Q30439814 | Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase |
Q24337412 | Interaction of the p85 subunit of PI 3-kinase and its N-terminal SH2 domain with a PDGF receptor phosphorylation site: structural features and analysis of conformational changes |
Q36686508 | Interactions between SH2 domains and tyrosine-phosphorylated platelet-derived growth factor beta-receptor sequences: analysis of kinetic parameters by a novel biosensor-based approach |
Q37359399 | Interferon-gamma-mediated activation of STAT1alpha regulates growth factor-induced mitogenesis. |
Q42674535 | Interleukin‐7 induces the association of phosphatidylinositol 3‐kinase with the α chain of the interleukin‐7 receptor |
Q35764632 | Intracellular signaling pathways required for rat vascular smooth muscle cell migration. Interactions between basic fibroblast growth factor and platelet-derived growth factor |
Q44124902 | Involvement of PI3-kinase and its association with c-Src in PTH-stimulated rat enterocytes |
Q41544830 | Involvement of a phosphotyrosine protein phosphatase in the suppression of platelet-derived growth factor receptor autophosphorylation in ras-transformed cells |
Q24315142 | Involvement of p72syk kinase, p53/56lyn kinase and phosphatidyl inositol-3 kinase in signal transduction via the human B lymphocyte antigen CD22 |
Q47756210 | Involvement of platelet-derived growth factor ligands and receptors in tumorigenesis |
Q34811265 | Involvement of regulatory and catalytic subunits of phosphoinositide 3-kinase in NF-kappaB activation. |
Q36325295 | Kinetics of p56lck and p60src Src homology 2 domain binding to tyrosine-phosphorylated peptides determined by a competition assay or surface plasmon resonance |
Q36273792 | Ligand-dependent transformation by the receptor for human granulocyte/macrophage colony-stimulating factor and tyrosine phosphorylation of the receptor beta subunit |
Q36550896 | Ligand-independent activation of the platelet-derived growth factor beta receptor: requirements for bovine papillomavirus E5-induced mitogenic signaling |
Q42805513 | Lovastatin inhibits platelet-derived growth factor (PDGF) stimulation of phosphatidylinositol 3-kinase activity as well as association of p85 subunit to tyrosine-phosphorylated PDGF receptor |
Q24306895 | Measurement of the binding of tyrosyl phosphopeptides to SH2 domains: a reappraisal |
Q40696307 | Mechanism by which cAMP activates PI3-kinase and increases bile acid secretion in WIF-B9 cells |
Q36669823 | Microinjection of the SH2 domain of the 85-kilodalton subunit of phosphatidylinositol 3-kinase inhibits insulin-induced DNA synthesis and c-fos expression |
Q36821017 | Modification of the 85-kilodalton subunit of phosphatidylinositol-3 kinase in platelet-derived growth factor-stimulated cells |
Q41101260 | Molecular basis of skeletal muscle regeneration |
Q24292745 | Molecular cloning and nucleic acid binding properties of the GAP-associated tyrosine phosphoprotein p62 |
Q35014319 | Molecular recognition by SH2 domains |
Q36487331 | Molecular separation of two signaling pathways for the receptor, Notch |
Q36236949 | Motogenic and morphogenic activity of epithelial receptor tyrosine kinases |
Q28587864 | Mutation of Tyr697, a GRB2-binding site, and Tyr721, a PI 3-kinase binding site, abrogates signal transduction by the murine CSF-1 receptor expressed in Rat-2 fibroblasts |
Q41077471 | Mutation of a Src phosphorylation site in the PDGF beta-receptor leads to increased PDGF-stimulated chemotaxis but decreased mitogenesis |
Q35846414 | Mutational analysis of the interaction between the bovine papillomavirus E5 transforming protein and the endogenous beta receptor for platelet-derived growth factor in mouse C127 cells. |
Q40790586 | Mutations in the Caenorhabditis elegans let-23 EGFR-like gene define elements important for cell-type specificity and function |
Q40791389 | Neuronal differentiation signals are controlled by nerve growth factor receptor/Trk binding sites for SHC and PLC gamma. |
Q40794603 | New insights into protein-tyrosine kinase receptor signaling complexes |
Q46205923 | Non-capacitative Calcium Entry in Chinese Hamster Ovary Cells Expressing the Platelet-derived Growth Factor Receptor |
Q38084894 | Nonredundant Functions for Ras GTPase-Activating Proteins in Tissue Homeostasis |
Q38314625 | Nonsense mutations in the C-terminal SH2 region of the GTPase activating protein (GAP) gene in human tumours |
Q30194476 | Oncogenes, protein tyrosine kinases, and signal transduction |
Q41355420 | PDGF stimulates an increase in GTP-Rac via activation of phosphoinositide 3-kinase |
Q28244045 | PDGF- and insulin-dependent pp70S6k activation mediated by phosphatidylinositol-3-OH kinase |
Q38615308 | PDGF-BB enhances collagen gel contraction through a PI3K-PLCγ-PKC-cofilin pathway |
Q40790718 | PI 3-kinase is a dual specificity enzyme: autoregulation by an intrinsic protein-serine kinase activity. |
Q40790710 | PI 3-kinase: structural and functional analysis of intersubunit interactions |
Q50297839 | PI3-kinase binds to the active receptor |
Q54527804 | PI3K signalling: the path to discovery and understanding |
Q22011152 | PSM, a mediator of PDGF-BB-, IGF-I-, and insulin-stimulated mitogenesis |
Q40715319 | Pathways of Ras function: connections to the actin cytoskeleton. |
Q30986609 | Peptide library screening for determination of SH2 or phosphotyrosine-binding domain sequences |
Q31992313 | Peptide modulators of protein–protein interactions in intracellular signaling |
Q24629183 | Phosphatidylinositol (PI) 3-kinase and PI 4-kinase binding to the CD4-p56lck complex: the p56lck SH3 domain binds to PI 3-kinase but not PI 4-kinase |
Q30452661 | Phosphatidylinositol 3-Kinase Is Required for Integrin-Stimulated AKT and Raf-1/Mitogen-Activated Protein Kinase Pathway Activation |
Q30194718 | Phosphatidylinositol 3-kinase activity is important for progesterone-induced Xenopus oocyte maturation |
Q41336419 | Phosphatidylinositol 3-kinase activity is required at a postendocytic step in platelet-derived growth factor receptor trafficking |
Q30167836 | Phosphatidylinositol 3-kinase p85 adaptor function in T-cells. Co-stimulation and regulation of cytokine transcription independent of associated p110. |
Q42807426 | Phosphatidylinositol 3-kinase signals activate a selective subset of Rac/Rho-dependent effector pathways |
Q40874030 | Phosphatidylinositol 3′-kinase associates with p145c-kit as part of a cell type characteristic multimeric signalling complex |
Q41489425 | Phosphatidylinositol-3 kinase activation induced upon Fc gamma RIIIA-ligand interaction |
Q41174456 | Phosphatidylinositol-3' kinase is not required for mitogenesis or internalization of the Flt3/Flk2 receptor tyrosine kinase |
Q29620177 | Phosphatidylinositol-3-OH kinase as a direct target of Ras |
Q42844293 | Phosphopeptide binding to the N‐terminal SH2 domain of the p85α subunit of PI 3′‐kinase: A heteronuclear NMR study |
Q40402454 | Phosphorylation of the nicotinic acetylcholine receptor by protein tyrosine kinases |
Q44729061 | Phosphorylation of tyrosine 1214 on VEGFR2 is required for VEGF-induced activation of Cdc42 upstream of SAPK2/p38. |
Q28289418 | Phosphorylation of tyrosine 503 in the erythropoietin receptor (EpR) is essential for binding the P85 subunit of phosphatidylinositol (PI) 3-kinase and for EpR-associated PI 3-kinase activity |
Q36564274 | Phosphorylation of tyrosine 720 in the platelet-derived growth factor alpha receptor is required for binding of Grb2 and SHP-2 but not for activation of Ras or cell proliferation |
Q28645716 | Phosphorylation sites at the C-terminus of the platelet-derived growth factor receptor bind phospholipase C gamma 1 |
Q34627225 | Phosphotyrosine-binding domains in signal transduction |
Q24336479 | Phosphotyrosine-independent binding of a 62-kDa protein to the src homology 2 (SH2) domain of p56lck and its regulation by phosphorylation of Ser-59 in the lck unique N-terminal region |
Q41662746 | Physiological Function of Receptor-SH2 Interactions |
Q42802895 | Platelet-derived growth factor (PDGF) receptor-alpha activates c-Jun NH2-terminal kinase-1 and antagonizes PDGF receptor-beta -induced phenotypic transformation |
Q41289581 | Platelet-derived growth factor (PDGF): actions and mechanisms in vascular smooth muscle |
Q41507086 | Platelet-derived growth factor induces phosphatidylinositol 3-kinase release from the middle T-pp60c-src complex and association with the platelet-derived growth factor receptor |
Q36690316 | Platelet-derived growth factor receptor can mediate tumorigenic transformation by the bovine papillomavirus E5 protein |
Q28645713 | Platelet-derived growth factor receptor mediates activation of ras through different signaling pathways in different cell types |
Q42807654 | Platelet-derived growth factor receptor tyrosine phosphorylation requires protein geranylgeranylation but not farnesylation |
Q40609877 | Platelet-derived growth factor receptor-mediated signal transduction from endosomes |
Q38258904 | Platelet-derived growth factor signaling in the lung. From lung development and disease to clinical studies |
Q34684084 | Platelet-derived growth factor triggers translocation of the insulin-regulatable glucose transporter (type 4) predominantly through phosphatidylinositol 3-kinase binding sites on the receptor |
Q36563209 | Platelet-derived growth factor-dependent activation of phosphatidylinositol 3-kinase is regulated by receptor binding of SH2-domain-containing proteins which influence Ras activity |
Q41480620 | Platelet-derived growth factor-induced phosphatidylinositol 3-kinase activation mediates actin rearrangements in fibroblasts |
Q40821933 | Platelet-derived growth factor. Structure, function and implications in normal and malignant cell growth |
Q46552554 | Point mutation of an FGF receptor abolishes phosphatidylinositol turnover and Ca2+ flux but not mitogenesis |
Q35569826 | Polyoma middle tumor antigen interacts with SHC protein via the NPTY (Asn-Pro-Thr-Tyr) motif in middle tumor antigen. |
Q52530471 | Polyomavirus Middle T Antigen as a Probe for T Cell Antigen Receptor-coupled Signaling Pathways |
Q41540271 | Pool of ligand‐bound platelet‐derived growth factor β‐receptors remain activated and tyrosine phosphorylated after internalization |
Q37385906 | Positive and negative tissue-specific signaling by a nematode epidermal growth factor receptor |
Q41038475 | Potentiation of insulin-induced phosphatidylinositol-3 kinase activity by phorbol ester is mediated by protein kinase C epsilon |
Q33888373 | Proliferative and apoptotic responses in cancers with special reference to oral cancer |
Q33719385 | Prospects for drug screening using the reverse two-hybrid system |
Q39446908 | Protein kinase A-dependent and -independent signaling pathways contribute to cyclic AMP-stimulated proliferation. |
Q29618388 | Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction |
Q39630940 | Protein kinase B activation and lamellipodium formation are independent phosphoinositide 3-kinase-mediated events differentially regulated by endogenous Ras. |
Q41191785 | Protein kinase C delta specifically associates with phosphatidylinositol 3-kinase following cytokine stimulation |
Q27860694 | Protein modules and signalling networks |
Q44878387 | Purification and Characterization of a Soluble Phosphatidylinositol 4-Kinase from Carrot Suspension Culture Cells |
Q42438790 | Purification and characterization of Gbetagamma-responsive phosphoinositide 3-kinases from pig platelet cytosol |
Q41442377 | Rapid and efficient purification of Src homology 2 domain-containing proteins: Fyn, Csk and phosphatidylinositol 3-kinase p85 |
Q24321244 | Rapid identification of phosphopeptide ligands for SH2 domains. Screening of peptide libraries by fluorescence-activated bead sorting |
Q73510887 | Ras signaling through PI3K confers hormone-independent proliferation that is compatible with differentiation |
Q39585343 | Ras-GAP binding and phosphorylation by herpes simplex virus type 2 RR1 PK (ICP10) and activation of the Ras/MEK/MAPK mitogenic pathway are required for timely onset of virus growth |
Q34465364 | RasGAP Promotes Autophagy and Thereby Suppresses Platelet-Derived Growth Factor Receptor-Mediated Signaling Events, Cellular Responses, and Pathology |
Q27729903 | Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck |
Q38350671 | Reexamining interaction of the SH2 domains of SYP and GAP with insulin and IGF-1 receptors in the two-hybrid system |
Q24322699 | Regulation of Vav-SLP-76 binding by ZAP-70 and its relevance to TCR zeta/CD3 induction of interleukin-2 |
Q41488423 | Regulation of chemotaxis by the platelet-derived growth factor receptor-beta |
Q33904740 | Regulation of phosphatidylinositol 3-kinase activity in liver and muscle of animal models of insulin-resistant and insulin-deficient diabetes mellitus |
Q46078497 | Relaxin activates the MAP kinase pathway in human endometrial stromal cells |
Q28143168 | Replacing two conserved tyrosines of the EphB2 receptor with glutamic acid prevents binding of SH2 domains without abrogating kinase activity and biological responses |
Q42803242 | Requirement of phosphatidylinositol 3-kinase activity for translocation of exogenous aFGF to the cytosol and nucleus |
Q41706399 | Retinal Astrocytes and GABAergic Wide-Field Amacrine Cells Express PDGFRα: Connection to Retinal Ganglion Cell Neuroprotection by PDGF-AA. |
Q35170183 | Retrograde factors in peripheral nerves |
Q24309394 | Role of CD4 and CD8 in T cell activation and differentiation |
Q30194282 | Role of IRS-1-GRB-2 complexes in insulin signaling |
Q41992885 | Role of phosphatidylinositol 3-OH-kinase activity in the inhibition of apoptosis in haemopoietic cells: phosphatidylinositol 3-OH-kinase inhibitors reveal a difference in signalling between interleukin-3 and granulocyte-macrophage colony stimulating |
Q29615222 | Role of platelet-derived growth factors in physiology and medicine |
Q36676458 | SH1 domain autophosphorylation of P210 BCR/ABL is required for transformation but not growth factor independence |
Q34057752 | SH2 domain specificity and activity modified by a single residue |
Q28199016 | Sam68 is a docking protein linking GAP and PI3K in insulin receptor signaling |
Q37334950 | Secondary structure of Src homology 2 domain of c-Abl by heteronuclear NMR spectroscopy in solution |
Q24313100 | Selective CD28pYMNM mutations implicate phosphatidylinositol 3-kinase in CD86-CD28-mediated costimulation |
Q42827298 | Selective Inhibition of p70 S6 Kinase Activation by Phosphatidylinositol 3‐Kinase Inhibitors |
Q38314926 | Separable portions of the CD2 cytoplasmic domain involved in signaling and ligand avidity regulation |
Q28513453 | Sequence requirements for binding of Src family tyrosine kinases to activated growth factor receptors |
Q34720232 | Serotonin transporter interacts with the PDGFβ receptor in PDGF-BB-induced signaling and mitogenesis in pulmonary artery smooth muscle cells |
Q40406776 | Signal transduction by Ras-like GTPases: a potential target for anticancer drugs |
Q40500421 | Signal transduction by the antigen receptors of B and T lymphocytes. |
Q28609164 | Signal transduction via platelet-derived growth factor receptors |
Q41559204 | Signaling Mechanisms in Growth Factor‐Stimulated Cell Motility |
Q41553992 | Simultaneous induction of stimulatory and inhibitory signals by PDGF |
Q22254150 | Site-selective dephosphorylation of the platelet-derived growth factor beta-receptor by the receptor-like protein-tyrosine phosphatase DEP-1 |
Q28645766 | Sodium-potassium-adenosinetriphosphatase-dependent sodium transport in the kidney: hormonal control |
Q28291452 | Specific binding of Fyn and phosphatidylinositol 3‐kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains |
Q29615971 | Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav |
Q24314456 | Specific phosphopeptide binding regulates a conformational change in the PI 3-kinase SH2 domain associated with enzyme activation |
Q36235805 | Sphingosine-1-phosphate inhibits PDGF-induced chemotaxis of human arterial smooth muscle cells: spatial and temporal modulation of PDGF chemotactic signal transduction |
Q22010243 | Src-family tyrosine kinases in activation of ERK-1 and p85/p110-phosphatidylinositol 3-kinase by G/CCKB receptors |
Q30194870 | Src-homology 3 domain of protein kinase p59fyn mediates binding to phosphatidylinositol 3-kinase in T cells |
Q24680080 | Stimulation of CD28 triggers an association between CD28 and phosphatidylinositol 3-kinase in Jurkat T cells |
Q42160617 | Stimulation of hyaluronan biosynthesis by platelet-derived growth factor-BB and transforming growth factor-beta 1 involves activation of protein kinase C. |
Q34305587 | Strongyloides stercoralis age-1: a potential regulator of infective larval development in a parasitic nematode. |
Q42826060 | Structural Requirements of the Epidermal Growth Factor Receptor for Tyrosine Phosphorylation of eps8 and eps15, Substrates Lacking Src SH2 Homology Domains |
Q24555662 | Structural and functional studies on platelet-derived growth factor |
Q27759524 | Structural basis for the high affinity of amino-aromatic SH2 phosphopeptide ligands |
Q41572802 | Structural requirement of CRK SH2 region for binding to phosphotyrosine-containing proteins. Evidence from reactivity to monoclonal antibodies |
Q24324349 | Structure of a specific peptide complex of the carboxy-terminal SH2 domain from the p85 alpha subunit of phosphatidylinositol 3-kinase |
Q27642078 | Structure of an SH2 domain of the p85 alpha subunit of phosphatidylinositol-3-OH kinase |
Q24317353 | Structure-activity studies of phosphorylated peptide inhibitors of the association of phosphatidylinositol 3-kinase with PDGF-beta receptor |
Q40490475 | Structure-function analyses of the kit receptor for the steel factor |
Q36872364 | Synthesis and characterization of histidine‐phosphorylated peptides |
Q35096703 | T cell anergy and costimulation |
Q28300793 | T cell antigen CD28 binds to the GRB-2/SOS complex, regulators of p21ras |
Q24310233 | T-cell antigen CD28 interacts with the lipid kinase phosphatidylinositol 3-kinase by a cytoplasmic Tyr(P)-Met-Xaa-Met motif |
Q74016240 | Tandem SH2 Domains Confer High Specificity in Tyrosine Kinase Signaling |
Q34393461 | Targeting the PDGF signaling pathway in tumor treatment |
Q24310396 | The 64-kDa protein that associates with the platelet-derived growth factor receptor beta subunit via Tyr-1009 is the SH2-containing phosphotyrosine phosphatase Syp |
Q40488860 | The CD19-CR2-TAPA-1 complex, CD45 and signaling by the antigen receptor of B lymphocytes |
Q41050852 | The Epidermal Growth Factor Receptor Associates with and Recruits Phosphatidylinositol 3-Kinase to the Platelet-derived Growth Factor β Receptor |
Q29618141 | The GTPase dynamin binds to and is activated by a subset of SH3 domains |
Q36551325 | The GTPase-activating protein of Ras suppresses platelet-derived growth factor beta receptor signaling by silencing phospholipase C-gamma 1 |
Q28287741 | The MATK tyrosine kinase interacts in a specific and SH2-dependent manner with c-Kit |
Q40733281 | The Ras signal transduction pathway |
Q24336226 | The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS1 and Shc: implications for insulin control of ras signalling |
Q24600605 | The SH2/SH3 domain-containing protein Nck is recognized by certain anti-phospholipase C-gamma 1 monoclonal antibodies, and its phosphorylation on tyrosine is stimulated by platelet-derived growth factor and epidermal growth factor treatment |
Q36485178 | The Src family tyrosine kinases are required for platelet-derived growth factor-mediated signal transduction in NIH 3T3 cells |
Q33933167 | The biochemical and physiological characteristics of receptors |
Q28367583 | The catalytic subunit of phosphatidylinositol 3-kinase is a substrate for the activated platelet-derived growth factor receptor, but not for middle-T antigen-pp60c-src complexes |
Q36235836 | The chemotactic response to PDGF-BB: evidence of a role for Ras. |
Q41469848 | The cytoplasmic domain of CD28 is both necessary and sufficient for costimulation of interleukin-2 secretion and association with phosphatidylinositol 3'-kinase |
Q58165507 | The hepatocyte growth factor receptor (MET): An unconventional transducer of mitogenic and motogenic signals |
Q36745695 | The interaction of small domains between the subunits of phosphatidylinositol 3-kinase determines enzyme activity |
Q35769059 | The phosphatidylinositol 3-kinase alpha is required for DNA synthesis induced by some, but not all, growth factors |
Q37454384 | The phosphoinositide 3-kinase pathway in human cancer: genetic alterations and therapeutic implications. |
Q73909431 | The phosphopeptide-binding specificity of Src family SH2 domains |
Q36678826 | The phosphotyrosine interaction domain of SHC recognizes tyrosine-phosphorylated NPXY motif |
Q37764745 | The regulation of class IA PI 3-kinases by inter-subunit interactions |
Q40454708 | The regulation of tyrosine kinase signalling pathways by growth factor and G-protein-coupled receptors. |
Q41568721 | The role of the IGF-1 receptor in the stimulation of cells by short pulses of growth factors |
Q40942505 | The synthesis and compositional analysis of phosphopeptides |
Q47806493 | Transmembrane signaling in periodontal mesenchymal cells: the linkage between stimulus and response |
Q41341486 | TrkA Tyrosine Residues Involved in NGF‐induced Neurite Outgrowth of PC12 Cells |
Q41323243 | Two SH2 Domains of p120 Ras GTPase-activating Protein Bind Synergistically to Tyrosine Phosphorylated p190 Rho GTPase-activating Protein |
Q40549695 | Two conserved cysteine residues are critical for the enzymic function of the human platelet-derived growth factor receptor-beta: evidence for different roles of Cys-822 and Cys-940 in the kinase activity |
Q24311075 | Two signaling molecules share a phosphotyrosine-containing binding site in the platelet-derived growth factor receptor |
Q24609334 | Tyr-716 in the platelet-derived growth factor beta-receptor kinase insert is involved in GRB2 binding and Ras activation |
Q40872205 | Tyrosine 785 is a major determinant of Trk--substrate interaction |
Q30452619 | Tyrosine 807 of the v-Fms oncogene product controls cell morphology and association with p120RasGAP |
Q54091334 | Tyrosine Phosphorylation of Insulin Receptor Substrate-1 and Activation of the PI-3-Kinase Pathway by Glycine-Extended Gastrin Precursors |
Q35156272 | Tyrosine phosphorylation and the mechanism of signal transduction by the B-lymphocyte antigen receptor |
Q42808291 | Tyrosine phosphorylation of the juxtamembrane domain of the v-Fms oncogene product is required for its association with a 55-kDa protein |
Q41157391 | Tyrosine residues in the granulocyte colony-stimulating factor (G-CSF) receptor mediate G-CSF-induced differentiation of murine myeloid leukemic (M1) cells. |
Q36658598 | Tyrosines 1021 and 1009 are phosphorylation sites in the carboxy terminus of the platelet-derived growth factor receptor beta subunit and are required for binding of phospholipase C gamma and a 64-kilodalton protein, respectively |
Q41010604 | Upstream-downstream: CD28 cosignaling pathways and T cell function |
Q55065488 | Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. Association with endothelial cell proliferation. |
Q27938850 | Vesicle-mediated protein transport: regulatory interactions between the Vps15 protein kinase and the Vps34 PtdIns 3-kinase essential for protein sorting to the vacuole in yeast |
Q40790197 | William L. McGuire Memorial Symposium. Control of breast cancer cell growth by steroids and growth factors: interactions and mechanisms |
Q41966849 | Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses. |
Q36561273 | YMXM motifs and signaling by an insulin receptor substrate 1 molecule without tyrosine phosphorylation sites |
Q30308392 | c-Src Tyrosine Phosphorylation of Epidermal Growth Factor Receptor, P190 RhoGAP, and Focal Adhesion Kinase Regulates Diverse Cellular Processes |
Q30193694 | src-homology 2 (SH2) domain ligation as an allosteric regulator: modulation of phosphoinositide-specific phospholipase C gamma 1 structure and activity |
Search more.